Reconsidering the usefulness of using long-acting injectable buprenorphine as a tapering tool: a case report of delayed withdrawal months after last dose - Quiz - MDSpire

Reconsidering the usefulness of using long-acting injectable buprenorphine as a tapering tool: a case report of delayed withdrawal months after last dose

  • By

  • Kareem Woods

  • Sophia Graham

  • Steven Dobscha

  • Christopher Blazes

  • July 6, 2026

  • 0 min

Share

Original Source(s)

Reconsidering the usefulness of using long-acting injectable buprenorphine as a tapering tool: a case report of delayed withdrawal months after last dose

  • by Kareem Woods, Sophia Graham, Steven Dobscha, Christopher Blazes

  • July 6, 2026

Related Content

Case Report: A literature review of the medical complications arising from etomidate-laced vapes and two case studies of hypokalemia associated with etomidate use

RFK Jr. presents $700 million in mental health funding, but experts say grants aren’t new

Shorter Initial Benzo Courses Linked to Discontinuation

Longer initial prescriptions, use of multiple benzodiazepines, and long-acting agents were associated with delayed discontinuation in a retrospective population-based cohort study.